N@N

WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting

_{//health-fitness.news-articles.net/content/2012/ .. ions-adopted-at-2012-annual-general-meeting.html}
^{Published in Health and Fitness on Tuesday, November 6th 2012 at 7:46 GMT by Market Wire}  

WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting -- SHANGHAI, Nov. 6, 2012 /PRNewswire/ --

SHANGHAI, Nov. 6, 2012 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: [ WX ]) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on November 6, 2012.

At the meeting, WuXi PharmaTech shareholders approved the re-election of incumbent Class B directors Xuesong (Jeff) Leng, Zhaohui Zhang, and Ning Zhao, each to serve a three-year term.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

SOURCE WuXi PharmaTech (Cayman) Inc.